Biomarkers of latent TB infection

References

• WHO Report. Global tuberculosis control: surveillance, planning financing. WHO/HTM/TB/2005. WHO, Geneva, Switzerland (2005).
   Google Scholar
• WHO Report. Global tuberculosis control: surveillance, planning, financing. WHO, Geneva, Switzerland (2008).
   Google Scholar
• Keane J. TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. Rheumatology44, 714–720 (2005).
   PubMed Web of Science ®Google Scholar
• Frothingham R, Stout JE, Hamilton CD. Current issues in global tuberculosis control. Int. J. Infect. Dis.9, 297–311 (2005).
   PubMed Web of Science ®Google Scholar
• Giri PK, Khuller GK. Is intranasal vaccination a feasible solution for tuberculosis? Expert Rev. Vaccines7(9), 1341–1356 (2008).
   PubMed Web of Science ®Google Scholar
• Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm. Rep.49, 1–51 (2000).
   PubMedGoogle Scholar
• Mazurek GH, Villarino ME. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. CDC. MMWR Recomm. Rep.52, 15–18 (2003).
   PubMedGoogle Scholar
• Cunningham J, Perkins M; WHO/TDR Tuberculosis Diagnostics Economic Working Group. Diagnostics for Tuberculosis. Global Demand and Market Potential. WHO, Geneva, Switzerland (2008).
   Google Scholar
• Atkinson AJ, Colburn WA, DeGruttola VG et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther.69, 89–95 (2001).
   PubMed Web of Science ®Google Scholar
• Mack U, Migliori GB, Sester M et al.; TBNET CLft. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur. Respir. J.33, 956–973 (2009).
   PubMed Web of Science ®Google Scholar
• Larsen MV, Sorensen IJ, Thomsen VO, Ravn P. Re-activation of bovine tuberculosis in a patient treated with infliximab. Eur. Respir. J.32, 229–231 (2008).
   PubMedGoogle Scholar
• Lillebaek T, Bergstedt W, Tingskov PN et al. Risk of sensitization in healthy adults following repeated administration of rdESAT-6 skin test reagent by the Mantoux injection technique. Tuberculosis (Edinb.)89, 158–162 (2009).
   PubMedGoogle Scholar
• van der Wel N, Hava D, Houben D et al.M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell129, 1287–1298 (2007).
   PubMed Web of Science ®Google Scholar
• Winau F, Weber S, Sad S et al. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity24, 105–117 (2006).
   PubMed Web of Science ®Google Scholar
• Krutzik SR, Modlin RL. The role of Toll-like receptors in combating mycobacteria. Semin. Immunol.16, 35–41 (2004).
   PubMed Web of Science ®Google Scholar
• Flynn JL, Chan J. Immunology of tuberculosis. Ann. Rev. Immunol.19, 93–129 (2001).
   PubMed Web of Science ®Google Scholar
• Sharma SK, Mohan A, Sharma A, Mitra DK. Miliary tuberculosis: new insights into an old disease. Lancet Infect. Dis.5, 415–430 (2005).
   PubMed Web of Science ®Google Scholar
• Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Ann. Rev. Immunol.26, 677–704 (2008).
   PubMed Web of Science ®Google Scholar
• Kaufmann SHE, Parida SK. Tuberculosis in Africa: learning from pathogenesis for biomarker identification. Cell Host Microbe4, 219–228 (2008).
   PubMedGoogle Scholar
• Kaufmann SHE. How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol.1, 20–30 (2001).
   PubMed Web of Science ®Google Scholar
• Saunders BM, Britton WJ. Life and death in the granuloma: immunopathology of tuberculosis. Immunol. Cell. Biol.85, 103–111 (2007).
   PubMed Web of Science ®Google Scholar
• Di Liberto D, Locati M, Caccamo N et al. Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection. J. Exp. Med.205(9), 2075–2084 (2008).
   PubMedGoogle Scholar
• Hougardy JM, Verscheure V, Locht C, Mascart F. In vitro expansion of CD4+CD25highFOXP3+CD127low/- regulatory T cells from peripheral blood lymphocytes of healthy Mycobacterium tuberculosis-infected humans. Microbes Infect.9, 1325–1332 (2007).
   PubMed Web of Science ®Google Scholar
• Scott-Browne JP, Shafiani S, Tucker-Heard G et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J. Exp. Med.204, 2159–2169 (2007).
   PubMed Web of Science ®Google Scholar
• Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJC, John S, Taams LS. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl Acad. Sci. USA104, 19446–19451 (2007).
   PubMed Web of Science ®Google Scholar
• Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front. Biosci.13, 453–461 (2008).
   PubMed Web of Science ®Google Scholar
• Viola A, Luster AD. Chemokines and their receptors: drug targets in immunity and inflammation. Annu. Rev. Pharmacol. Toxicol.48, 171–197 (2008).
   PubMed Web of Science ®Google Scholar
• Allen SJ, Crown SE, Handel TM. Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol.25, 787–820 (2007).
   PubMed Web of Science ®Google Scholar
• Thelen M, Stein J. How chemokines invite leukocytes to dance. Nat. Immunol.9, 953–959 (2008).
   PubMed Web of Science ®Google Scholar
• Bromley SK, Mempel TR, Luster AD. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol.9, 970–980 (2008).
   PubMed Web of Science ®Google Scholar
• Lande R, Giacomini E, Grassi T et al. IFN-αβ released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J. Immunol.170, 1174–1182 (2003).
   PubMed Web of Science ®Google Scholar
• Qu C, Edwards EW, Tacke F et al. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J. Exp. Med.200, 1231–1241 (2004).
   PubMed Web of Science ®Google Scholar
• Chiu BC, Freeman CM, Stolberg VR et al. Cytokine–chemokine networks in experimental mycobacterial and schistosomal pulmonary granuloma formation. Am. J. Respir. Cell Mol. Biol.29, 106–116 (2003).
   PubMedGoogle Scholar
• Jang S, Uzelac A, Salgame P. Distinct chemokine and cytokine gene expression pattern of murine dendritic cells and macrophages in response to Mycobacterium tuberculosis infection. J. Leukoc. Biol.84, 1264–1270 (2008).
   PubMedGoogle Scholar
• Jeyanathan M, Mu J, Kugathasan K et al. Airway delivery of soluble mycobacterial antigens restores protective mucosal immunity by single intramuscular plasmid DNA tuberculosis vaccination: role of proinflammatory signals in the lung. J. Immunol.181, 5618–5626 (2008).
   PubMed Web of Science ®Google Scholar
• Kaplan G, Luster AD, Hancock G, Cohn ZA. The expression of a γ interferon-induced protein (IP-10) in delayed immune responses in human skin. J. Exp. Med.166, 1098–1108 (1987).
   PubMed Web of Science ®Google Scholar
• Molesworth-Kenyon S, Mates A, Yin R, Strieter R, Oakes J, Lausch R. CXCR3, IP-10, and Mig are required for CD4+ T cell recruitment during the DTH response to HSV-1 yet are independent of the mechanism for viral clearance. Virology333, 1–9 (2005).
   PubMed Web of Science ®Google Scholar
• Steingart KR, Henry M, Laal S et al. Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med.4, e202 (2007).
   PubMed Web of Science ®Google Scholar
• Bagheri K, Delirezh N, Moazzeni SM. PPD extract induces the maturation of human monocyte-derived dendritic cells. Immunopharmacol. Immunotoxicol.30, 91–104 (2008).
   PubMed Web of Science ®Google Scholar
• Harboe M. Antigens of PPD, old tuberculin, and autoclaved Mycobacterium bovis BCG studied by crossed immunoelectrophoresis. Am. Rev. Respir. Dis.124, 80–87 (1981).
   PubMedGoogle Scholar
• Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin. Infect. Dis.17, 968–975 (1993).
   PubMed Web of Science ®Google Scholar
• Arend SM, Franken WP, Aggerbeck H et al. Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection. Tuberculosis (Edinb.)88, 249–261 (2008).
   PubMedGoogle Scholar
• Davies MA, Connell T, Johannisen C et al. Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay. AIDS23, 961–969 (2009).
   PubMed Web of Science ®Google Scholar
• Ferrara G, Losi M, D’Amico R et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet367, 1328–1334 (2006).
   PubMed Web of Science ®Google Scholar
• Jones S, de Gijsel D, Wallach FR, Gurtman AC, Shi Q, Sacks H. Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int. J. Tuberc. Lung Dis.11, 1190–1195 (2007).
   PubMed Web of Science ®Google Scholar
• Karam F, Mbow F, Fletcher H et al. Sensitivity of IFN-γ release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS ONE3, e1441 (2008).
   PubMedGoogle Scholar
• Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet364, 2196–2203 (2004).
   PubMed Web of Science ®Google Scholar
• Luetkemeyer AF, Charlebois ED, Flores LL et al. Comparison of an interferon-γ release assay with tuberculin skin testing in HIV-infected individuals. Am. J. Respir. Crit. Care Med.175, 737–742 (2007).
   PubMed Web of Science ®Google Scholar
• Mandalakas AM, Hesseling AC, Chegou NN et al. High level of discordant IGRA results in HIV-infected adults and children. Int. J. Tuberc. Lung Dis.12, 417–423 (2008).
   PubMed Web of Science ®Google Scholar
• Rangaka MX, Wilkinson KA, Seldon R et al. Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am. J. Respir. Crit. Care Med.175, 514–520 (2007).
   PubMed Web of Science ®Google Scholar
• Richeldi L, Losi M, D’Amico R et al. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest doi: 10.1378/chest.08-2575 (Epub ahead of print) (2009).
   PubMedGoogle Scholar
• Stephan C, Wolf T, Goetsch U et al. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS22, 2471–2479 (2008).
   PubMedGoogle Scholar
• Talati N, Seybold U, Humphrey B et al. Poor concordance between interferon-γ release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect. Dis.9, 15 (2009).
   PubMedGoogle Scholar
• Pai M, Lewinsohn DM. interferon-γ assays for tuberculosis: is anergy the Achilles’ heel? Am. J. Respir. Crit. Care Med.172, 519–521 (2005).
   PubMedGoogle Scholar
• Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev. Mol. Diagn.6, 423–432 (2006).
   PubMed Web of Science ®Google Scholar
• Pai M, O’Brien R. Tuberculosis diagnostics trials: do they lack methodological rigor? Expert Rev. Mol. Diagn.6(4), 509–514 (2006).
   PubMed Web of Science ®Google Scholar
• Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med.149, 177–184 (2008).
   PubMed Web of Science ®Google Scholar
• Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet356, 1099–1104 (2000).
   PubMed Web of Science ®Google Scholar
• Berthet FX, Rasmussen PB, Rosenkrands I, Andersen P, Gicquel B. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology144(Pt 11), 3195–3203 (1998).
   PubMed Web of Science ®Google Scholar
• Brock I, Weldingh K, Leyten EM, Arend SM, Ravn P, Andersen P. Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J. Clin. Microbiol.42, 2379–2387 (2004).
   PubMed Web of Science ®Google Scholar
• Leyten EM, Lin MY, Franken KL et al. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect.8, 2052–2060 (2006).
   PubMed Web of Science ®Google Scholar
• Harada N, Higuchi K, Yoshiyama T et al. Comparison of the sensitivity and specificity of two whole blood interferon-γ assays for M. tuberculosis infection. J. Infect.56, 348–353 (2008).
   PubMed Web of Science ®Google Scholar
• Bakir M, Millington KA, Soysal A et al. Prognostic value of a T-cell-based, interferon-γ biomarker in children with tuberculosis contact. Ann. Intern. Med.149, 777–786 (2008).
   PubMed Web of Science ®Google Scholar
• Hill PC, Jackson-Sillah DJ, Fox A et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS ONE3, e1379 (2008).
   PubMedGoogle Scholar
• Goletti D, Carrara S, Mayanja-Kizza H et al. Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study. BMC Infect. Dis.8, 11 (2008).
   PubMed Web of Science ®Google Scholar
• Aabye MG, Ravn P, PrayGod G et al. The impact of HIV infection and CD4 cell count on the performance of an interferon γ release assay in patients with pulmonary tuberculosis. PLoS ONE4, e4220 (2009).
   Google Scholar
• Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-γ test. Respir. Res.7, 56 (2006).
   PubMed Web of Science ®Google Scholar
• Luetkemeyer AF, Charlebois ED, Flores LL et al. Comparison of an interferon-γ release assay with tuberculin skin testing in HIV-infected individuals. Am. J. Respir. Crit. Care Med.175, 737–742 (2007).
   PubMed Web of Science ®Google Scholar
• Perkins MD, Small PM. Admitting defeat. Int. J. Tuberc. Lung Dis.10, 1 (2006).
   PubMedGoogle Scholar
• Small PM, Perkins MD. More rigour needed in trials of new diagnostic agents for tuberculosis. Lancet356, 1048–1049 (2000).
   PubMedGoogle Scholar
• Soborg B, Ruhwald M, Hetland M et al. Comparison of screening procedures for M. tuberculosis infection among patients with inflammatory diseases. J. Rheumatol. (In press) (2009).
   Google Scholar
• Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med.146, 340–354 (2007).
   PubMed Web of Science ®Google Scholar
• Ponce de LD, Cevedo-Vasquez E, Alvizuri S et al. Comparison of an interferon-γ assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J. Rheumatol.35, 776–781 (2008).
   PubMedGoogle Scholar
• Pai M, Joshi R, Dogra S, Zwerling AA et al. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int. J. Tuberc. Lung Dis.13, 84–92 (2009).
   PubMed Web of Science ®Google Scholar
• Harada N, Higuchi K, Sekiya Y, Rothel J, Kitoh T, Mori T. Basic characteristics of a novel diagnostic method (QuantiFERON TB-2G) for latent tuberculosis infection with the use of Mycobacterium tuberculosis-specific antigens, ESAT-6 and CFP-10. Kekkaku79, 725–735 (2004).
   PubMedGoogle Scholar
• Schuck SD, Mueller H, Kunitz F et al. Identification of T-cell antigens specific for latent Mycobacterium tuberculosis infection. PLoS ONE4, e5590 (2009).
   PubMed Web of Science ®Google Scholar
• KawamuraM. tuberculosis screening of contacts and HCWs in San Francisco. Presented at: 2nd Global Symposium on IGRAs. Duborvnik, Croatia, 29 May–1 June, 2009.
   Google Scholar
• Doherty TM, Demissie A, Olobo J et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J. Clin. Microbiol.40, 704–706 (2002).
   PubMed Web of Science ®Google Scholar
• Hill PC, Jackson-Sillah DJ, Fox A et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS ONE3(1), e1379 (2008).
   PubMedGoogle Scholar
• Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-γ assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med.177, 1164–1170 (2008).
   PubMed Web of Science ®Google Scholar
• Aichelburg MC, Rieger A, Breitenecker F et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-γ release assay in HIV-1-infected individuals. Clin. Infect. Dis.48, 954–962 (2009).
   PubMed Web of Science ®Google Scholar
• Andersen P, Doherty TM, Pai M, Weldingh K. The prognosis of latent tuberculosis: can disease be predicted? Trends Mol. Med.13, 175–182 (2007).
   PubMed Web of Science ®Google Scholar
• Higuchi K, Harada N, Fukazawa K, Mori T. Relationship between whole-blood interferon-γ responses and the risk of active tuberculosis. Tuberculosis (Edinb.)88, 244–248 (2008).
   PubMedGoogle Scholar
• Jacobsen M, Mattow J, Repsilber D, Kaufmann SHE. Novel strategies to identify biomarkers in tuberculosis. Biol. Chem.389, 487–495 (2008).
   PubMed Web of Science ®Google Scholar
• Wallis RS, Doherty TM, Onyebujoh P et al. Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect. Dis.9, 162–172 (2009).
   PubMed Web of Science ®Google Scholar
• Doherty M, Wallis RS, Zumla A; WHO-Tropical Disease Research/European Commission joint expert consultation group. Biomarkers for tuberculosis disease status and diagnosis. Curr. Opin. Pulmon. Med.15(3), 181–187 (2009).
   PubMed Web of Science ®Google Scholar
• Walzl G, Ronacher K, Djoba Siawaya JF, Dockrell HM. Biomarkers for TB treatment response: challenges and future strategies. J. Infect.57, 103–109 (2008).
   PubMed Web of Science ®Google Scholar
• Pai M, Riley LW, Colford JM Jr. interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect. Dis.4, 761–776 (2004).
   PubMed Web of Science ®Google Scholar
• Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev. Mol. Diagn.6(3), 413–422 (2006).
   PubMed Web of Science ®Google Scholar
• Petrovsky N, Harrison LC. Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance? J. Immunol.158, 5163–5168 (1997).
   PubMed Web of Science ®Google Scholar
• Arend SM, Thijsen SFT, Leyten EMS et al. Comparison of two interferon-γ assays and tuberculin skin test for tracing tuberculosis contacts. Am. J. Respir. Crit. Care Med.175, 618–627 (2007).
   PubMed Web of Science ®Google Scholar
• Leyten EMS, Arend SM, Prins C, Cobelens FGJ, Ottenhoff THM, van Dissel JT. Discrepancy between Mycobacterium tuberculosis-specific γ interferon release assays using short and prolonged in vitro incubation. Clin. Vaccine Immunol.14, 880–885 (2007).
   PubMed Web of Science ®Google Scholar
• Munk ME, Arend SM, Brock I, Ottenhoff THM, Andersen P. Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis. J. Infect. Dis.183, 175–176 (2001).
   PubMedGoogle Scholar
• Ravn P, Demissie A, Eguale T et al. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J. Infect. Dis.179, 637–645 (1999).
   PubMed Web of Science ®Google Scholar
• Aagaard C, Brock I, Olsen A, Ottenhoff THM, Weldingh K, Andersen P. Mapping immune reactivity toward Rv2653 and Rv2654: two novel low-molecular-mass antigens found specifically in the Mycobacterium tuberculosis complex. J. Infect. Dis.189, 812–819 (2004).
   PubMed Web of Science ®Google Scholar
• Savolainen L, Pusa L, Kim HJ, Sillanpää H, Seppälä I, Tuuminen T. Pilot study of diagnostic potential of the Mycobacterium tuberculosis recombinant HBHA protein in a vaccinated population in Finland. PLoS ONE3, e3272 (2008).
   PubMedGoogle Scholar
• Feske M, Nudelman RJ, Medina M et al. Enhancement of human antigen-specific memory T-cell responses by interleukin-7 may improve accuracy in diagnosing tuberculosis. Clin. Vaccine Immunol.15, 1616–1622 (2008).
   PubMedGoogle Scholar
• Denis M, Wedlock DN, McCarthy AR et al. Enhancement of the sensitivity of the whole-blood γ interferon assay for diagnosis of Mycobacterium bovis infections in cattle. Clin. Vaccine Immunol.14, 1483–1489 (2007).
   PubMedGoogle Scholar
• Li L, Lao SH, Wu CY. Increased frequency of CD4+CD25high Treg cells inhibit BCG-specific induction of IFN-γ by CD4+ T cells from TB patients. Tuberculosis87, 526–534 (2007).
   PubMedGoogle Scholar
• Jennes W, Kestens L, Nixon DF, Shacklett BL. Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15– the Amplispot assay. J. Immunol. Method270, 99–108 (2002).
   PubMedGoogle Scholar
• Calarota SA, Otero M, Hermanstayne K et al. Use of interleukin 15 to enhance interferon-γ production by antigen-specific stimulated lymphocytes from rhesus macaques. J. Immunol. Method.279, 55–67 (2003).
   PubMedGoogle Scholar
• Kuerten S, Schlingmann TR, Rajasalu T, Angelov DN, Lehmann PV, Tary-Lehmann M. Lack of disease specificity limits the usefulness of in vitro costimulation in HIV- and HCV-infected patients. Clin. Dev. Immunol.2008, 590941 (2008).
   PubMedGoogle Scholar
• Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur. J. Immunol.39, 723–729 (2009).
   PubMed Web of Science ®Google Scholar
• Ulrichs T, Munk ME, Mollenkopf H et al. Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur. J. Immunol.28, 3949–3958 (1998).
   PubMed Web of Science ®Google Scholar
• Millington KA, Innes JA, Hackforth S et al. Dynamic relationship between IFN-γ and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J. Immunol.178, 5217–5226 (2007).
   PubMed Web of Science ®Google Scholar
• Hughes AJ, Hutchinson P, Gooding T, Freezer NJ, Holdsworth SR, Johnson PD. Diagnosis of Mycobacterium tuberculosis infection using ESAT-6 and intracellular cytokine cytometry. Clin. Exp. Immunol.142, 132–139 (2005).
   PubMedGoogle Scholar
• Ruhwald M, Bjerregaard-Andersen M, Rabna P, Kofoed K, Eugen-Olsen J, Ravn P. IP-10/CXCL10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes. Infect.9, 806–812 (2007).
   PubMed Web of Science ®Google Scholar
• Ruhwald M, Petersen J, Kofoed K et al. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS ONE3, e2858 (2008).
   PubMed Web of Science ®Google Scholar
• Brice GT, Graber NL, Hoffman SL, Doolan DL. Expression of the chemokine MIG is a sensitive and predictive marker for antigen-specific, genetically restricted IFN-γ production and IFN-γ-secreting cells. J. Immunol. Method.257, 55–69 (2001).
   PubMedGoogle Scholar
• Abramo C, Meijgaarden KE, Garcia D et al. Monokine induced by interferon g and IFN-γ response to a fusion protein of Mycobacterium tuberculosis ESAT-6 and CFP-10 in Brazilian tuberculosis patients. Microbes Infect.8, 45–51 (2006).
   PubMedGoogle Scholar
• Fitzgerald-Bocarsly P, Feng D. The role of type I interferon production by dendritic cells in host defense. Biochimie89, 843–855 (2007).
   PubMed Web of Science ®Google Scholar
• Ho HH, Ivashkiv LB. Role of STAT3 in type I interferon responses: negative regulation of STAT1-dependent inflammatory gene activation. J. Biol. Chem.281, 14111–14118 (2006).
   PubMedGoogle Scholar
• Petrucci R, Abu AN, Gurgel RQ et al. Interferon γ, interferon-γ-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection. Pediatr. Infect. Dis. J.27, 1073–1077 (2008).
   PubMedGoogle Scholar
• Ruhwald M, Bjerregaard-Andersen M, Rabna P, Eugen-Olsen J, Ravn P. IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. BMC Res. Notes2, 19 (2009).
   PubMedGoogle Scholar
• Whittaker E, Gordon A, Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNγ? PLoS ONE3, e3901 (2008).
   PubMed Web of Science ®Google Scholar
• Zhou X-H, Obuchowski NA, McClish DK. Statistical Methods in Diagnostic Medicine. John Wiley & Sons, NY, USA (2002).
   Google Scholar
• Ruhwald M, Bodmer T, Maier C et al.; on behalf of TBNET. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of TB. Eur. Respir. J.32(6), 1428–1430 (2008).
   PubMedGoogle Scholar
• Ruhwald M. Improving T-cell assays for the diagnosis of active and latent TB infection using IP-10. Presented at: 2nd Global Symposium on IGRAs. Duborvnik, Croatia, 29 May–1 June, 2009.
   Google Scholar
• Lighter J, Rigaud M, Huie M, Peng CH, Pollack H. Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children. Int. J. Tuberc. Lung Dis.13, 731–736 (2009).
   PubMedGoogle Scholar
• Demissie A, Leyten EM, Abebe M et al. Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clin. Vaccine Immunol.13, 179–186 (2006).
   PubMed Web of Science ®Google Scholar
• Hougardy JM, Schepers K, Place S et al. Heparin-binding-hemagglutinin-induced IFN-γ release as a diagnostic tool for latent tuberculosis. PLoS ONE2, e926 (2007).
   PubMed Web of Science ®Google Scholar
• Siawaya JF, Bapela NB, Ronacher K, Beyers N, van Helden P, Walzl G. Differential expression of interleukin-4 (IL-4) and IL-4 δ 2 mRNA, but not transforming growth factor β (TGF-β), TGF-β RII, Foxp3, γ interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responses to antituberculosis treatment. Clin. Vaccine Immunol.15, 1165–1170 (2008).
   PubMedGoogle Scholar
• Wassie L, Demissie A, Aseffa A et al.Ex vivo cytokine mRNA levels correlate with changing clinical status of ethiopian TB patients and their contacts over time. PLoS ONE3, e1522 (2008).
   Google Scholar
• Wu B, Huang C, Kato-Maeda M et al. Messenger RNA expression of IL-8, FOXP3, and IL-12β differentiates latent tuberculosis infection from disease. J. Immunol.178, 3688–3694 (2007).
   PubMedGoogle Scholar
• Diel R, Nienhaus A, Lange C, Meywald-Walter K, Forssbohm M, Schaberg T. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir. Res.7, 77 (2006).
   PubMedGoogle Scholar
• Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Oka M. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment. J. Infect.58, 197–204 (2009).
   PubMedGoogle Scholar
• Higuchi K, Harada N, Mori T. interferon-γ responses after isoniazid chemotherapy for latent tuberculosis. Respirology13, 468–472 (2008).
   PubMedGoogle Scholar
• Herrmann JL, Belloy M, Porcher R et al. Temporal dynamics of interferon g responses in children evaluated for tuberculosis. PLoS ONE4, e4130 (2009).
   Google Scholar
• Djoba Siawaya JF, Bapela NB, Ronacher K et al. Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response. J. Infect.56, 340–347 (2008).
   PubMed Web of Science ®Google Scholar
• Djoba Siawaya JF, Ruhwald M, Eugen-Olsen J, Walzl G. Correlates for disease progression and prognosis during concurrent HIV/TB infection. Int. J. Infect. Dis.11, 289–299 (2007).
   PubMedGoogle Scholar
• Eugen-Olsen J, Gustafson P, Sidenius N et al. The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea–Bissau. Int. J. Tuberc. Lung Dis.6, 686–692 (2002).
   PubMed Web of Science ®Google Scholar
• Immanuel C, Swamy R, Kannapiran M et al. Neopterin as a marker for cell-mediated immunity in patients with pulmonary tuberculosis. Int. J. Tuberc. Lung Dis.1, 175–180 (1997).
   PubMedGoogle Scholar
• Tozkoparan E, Deniz O, Cakir E et al. The diagnostic values of serum, pleural fluid and urine neopterin measurements in tuberculous pleurisy. Int. J. Tuberc. Lung Dis.9, 1040–1045 (2005).
   PubMed Web of Science ®Google Scholar
• Azzurri A, Sow OY, Amedei A et al. IFN-γ-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect.7, 1–8 (2005).
   PubMed Web of Science ®Google Scholar
• Djoba Siawaya JF, Beyers N, van Helden P, Walzl G. Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis. Clin. Exp. Immunol.156, 69–77 (2009).
   PubMed Web of Science ®Google Scholar